Key facts
- Notable investors include Shandong Shichuang Equity Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Dahua Kate
- ·The full record, as it builds
Funding rounds
No funding rounds for Dahua Kate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dahua Kate
Manufacturer of cell therapy technologies aims to advance innovative healthcare solutions for cancer treatment. The company's offerings feature targeted cell therapy platforms, breakthrough oncology treatment technologies, and healthcare service integration, helping patients benefit from more precise and effective cancer therapies, enabling improved clinical outcomes and broader accessibility of next-generation cancer treatments.
- Sector
- Healthcare
- HQ
- Jinan, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Dahua Kate doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dahua Kate shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dahua Kate in its N-PORT filings yet. We sweep new filings monthly.